Trial · NCT00656201
Comparison of Crinone 8% Intravaginal Gel and IM Progesterone Supplementation for In Vitro Fertilization (IVF)
NCT00656201, Phase 4, Completed, Brigham and Women's Hospital; results first posted 2011-09-20
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Comparison of Crinone 8% Intravaginal Gel and IM Progesterone Supplementation for In Vitro Fertilization (IVF). Trials, record NCT00656201. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00656201
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Comparison of Crinone 8% Intravaginal Gel and IM Progesterone Supplementation for In Vitro Fertilization (IVF)
- NCT number
- NCT00656201
- Status
- Completed
- Phases
- Phase 4
- Enrollment
- 468 participants, actual
- Lead sponsor
- Brigham and Women's Hospital
- Conditions
- Infertility
- Interventions
- Crinone 8% Vaginal Gel, Intramuscular Progesterone
- First posted
- 2008-04-10
- Last updated
- 2011-09-22
- Results first posted
- 2011-09-20
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Percentage of Pregnant Patients After IVF Treatments | 16 weeks | Percentage of pregnant patients after IVF treatments who received either Crinone or IM Progesterone after oocyte retrieval |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Percentage of Pregnant Patients After IVF Treatments | 16 weeks | Number of participants for analysis was determined by completion of the IVF cycle using the specified medications, either Crinone or IM Progesterone | percentage of participants | NUMBER |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Pregnant Patients After IVF Treatments | Crinone 8% Vaginal Gel | 66 | 80 to 180 | percentage of participants | |
| Percentage of Pregnant Patients After IVF Treatments | Intramuscular Progesterone | 62 | 80 to 180 | percentage of participants |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Crinone 8% Vaginal Gel | 235 | |
| Overall Study | STARTED | Intramuscular Progesterone | 233 | |
| Overall Study | COMPLETED | Crinone 8% Vaginal Gel | 206 | |
| Overall Study | COMPLETED | Intramuscular Progesterone | 201 | |
| Overall Study | NOT COMPLETED | Crinone 8% Vaginal Gel | 29 | |
| Overall Study | NOT COMPLETED | Intramuscular Progesterone | 32 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Crinone 8% Vaginal Gel | ||
| Total, all-cause mortality | Intramuscular Progesterone | ||
| Total, other adverse events | Crinone 8% Vaginal Gel | 0 | 206 |
| Total, other adverse events | Intramuscular Progesterone | 0 | 201 |
| Total, serious adverse events | Crinone 8% Vaginal Gel | 0 | 206 |
| Total, serious adverse events | Intramuscular Progesterone | 0 | 201 |
Source ClinicalTrials.gov
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 20347079 | RESULT |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons1
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison |
|---|
| Crinone 8% Vaginal Gel vs Intramuscular Progesterone: serious adverse events |
Source Trial comparisons
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00656201
GET https://conductscience.org/api/trials/v1/NCT00656201/registered